Tailored-dose chemotherapy with gemcitabine and irinotecan in patients with platinum-refractory/resistant ovarian or primary peritoneal cancer: a phase II trial

OBJECTIVE: We investigated the efficacy and toxicity of tailored-dose chemotherapy with gemcitabine and irinotecan for platinum-refractory/resistant ovarian or primary peritoneal cancer. METHODS: We enrolled patients with ovarian or primary peritoneal cancer who received ≥2 previous chemotherapeutic...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Gynecol Oncol
Main Authors: Tate, Shinichi, Nishikimi, Kyoko, Matsuoka, Ayumu, Otsuka, Satoyo, Kato, Kazuyoshi, Takahashi, Yutaka, Shozu, Makio
Format: Artigo
Jezik:Inglês
Izdano: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2020
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7767653/
https://ncbi.nlm.nih.gov/pubmed/33185049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2021.32.e8
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki